N
Novo A/S
Novo A/S is an institution, managing $1.5B across 26 long positions as of Q3 2025 with 45% Healthcare concentration, 75% concentrated in top 10 holdings, and 22% allocation to VTI.
- Portfolio Value
- $1.5B
- Positions
- 26
- Top Holding
- VTI at 22.38%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in Novo A/S's portfolio (74.5% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
ETF ETF | $340.8M | 22.38% | — | — 1.0M shares | |
Asset Management Financial Services | $159.8M | 10.50% | — | 0.16% 2.3M shares | |
Unknown Unknown | $141.2M | 9.27% | -$19.4M Sold | — 145.8K shares | |
Biotechnology Healthcare | $92.7M | 6.08% | -$17.3M Sold | 2.52% 1.3M shares | |
Biotechnology Healthcare | $86.8M | 5.70% | — | 5.08% 5.4M shares | |
Software - Application Technology | $78.3M | 5.14% | — | 0.03% 330.2K shares | |
Biotechnology Healthcare | $70.6M | 4.64% | — | 0.99% 750.0K shares | |
Biotechnology Healthcare | $67.7M | 4.44% | +$3.1M Bought | 1.73% 1.6M shares | |
Biotechnology Healthcare | $51.4M | 3.37% | — | 2.91% 2.4M shares | |
Unknown Unknown | $46.0M | 3.02% | -$20.6M Sold | — 257.3K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in Novo A/S's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
New | |
+31.52% | |
+11.26% | |
+4.84% | |
+3.74% |
Decreased Positions
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
-70.59% | |
-30.89% |
Analytics
Portfolio insights and performance metrics for Novo A/S
GthenA